ID: ALA1939840

Max Phase: Preclinical

Molecular Formula: C19H12O4

Molecular Weight: 304.30

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): NSC-158109
Synonyms from Alternative Forms(1):

    Canonical SMILES:  O=c1ccc2c(-c3ccccc3O)c3ccc(O)cc3oc-2c1

    Standard InChI:  InChI=1S/C19H12O4/c20-11-5-7-14-17(9-11)23-18-10-12(21)6-8-15(18)19(14)13-3-1-2-4-16(13)22/h1-10,20,22H

    Standard InChI Key:  DTORADINSJYOQB-UHFFFAOYSA-N

    Associated Targets(Human)

    GNB1 Tbio Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1/gamma-2 (71 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    rmlD dTDP-4-dehydrorhamnose reductase (49 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 304.30Molecular Weight (Monoisotopic): 304.0736AlogP: 3.98#Rotatable Bonds: 1
    Polar Surface Area: 70.67Molecular Species: ACIDHBA: 4HBD: 2
    #RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 6.41CX Basic pKa: 2.94CX LogP: 3.05CX LogD: 2.02
    Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.52Np Likeness Score: 0.88

    References

    1. Wang Y, Hess TN, Jones V, Zhou JZ, McNeil MR, Andrew McCammon J..  (2011)  Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.,  21  (23): [PMID:22014548] [10.1016/j.bmcl.2011.09.094]
    2.  (2010)  Compositions and methods for inhibiting g protein signaling,